| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR13C6P OR6F1 OR2W3 OR2A4 OR10H5 OR4C45 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 6.71e-06 | 431 | 269 | 19 | GO:0004984 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 2.37e-05 | 5 | 269 | 3 | GO:0004749 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ERBB3 ABCA1 OR2A7 OR9G1 OR7C1 INSRR OR8S1 OR13G1 ACVR1 ADGRV1 PTCH1 PTGFR OR13J1 OR13C6P OR6F1 OR2W3 HMCN2 EDAR GPR158 OR2A4 FLT4 OR10H5 NTRK3 ROR1 OR4C45 GRIA3 GRIN1 OR4L1 OR9G9 OR51D1 OR52A5 IL17RE UNC5CL OR6K3 ROS1 OR13C7 OR4F15 | 3.14e-05 | 1353 | 269 | 37 | GO:0004888 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ERCC6L ABCA13 ATP10B ABCA10 ABCA8 KIF9 DNAH8 DNAH9 DDX11L8 DHX58 TWNK NLRP1 YTHDC2 DNAH12 SLFN13 MACF1 SLFN11 | 3.27e-05 | 441 | 269 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 4.69e-05 | 6 | 269 | 3 | GO:0016778 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.45e-05 | 31 | 269 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.45e-05 | 33 | 269 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.49e-05 | 18 | 269 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ERCC6L ABCA13 ATP10B ACSS2 ABCA10 ABCA8 KIF9 DNAH8 DNAH9 DDX11L8 DHX58 TWNK NLRP1 YTHDC2 DNAH12 SLFN13 DNAH17 MACF1 SLFN11 ATP6V0A2 | 9.50e-05 | 614 | 269 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA1 ABCA13 SLCO2B1 SLC39A11 PIEZO1 MCL1 SLC24A3 HCN2 SLC30A2 ABCA10 ABCA8 SLC16A12 RYR2 RYR3 ITPR1 SLC13A4 SLC22A10 TRPV2 SLC17A6 CACNA1A RHBG HCN3 GRIA3 GRIN1 ADAMTS8 SLC2A2 SLC3A1 SLC17A1 DISP2 DISP1 SLC4A11 ATP6V0A2 | 1.31e-04 | 1180 | 269 | 32 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ABCA1 ABCA13 SLCO2B1 SLC39A11 PIEZO1 MCL1 SLC24A3 ATP10B HCN2 SLC30A2 ABCA10 ABCA8 SLC16A12 RYR2 RYR3 ITPR1 SLC13A4 SLC22A10 TRPV2 SLC17A6 CACNA1A RHBG HCN3 GRIA3 GRIN1 ADAMTS8 SLC2A2 SLC3A1 SLC17A1 CIDEC DISP2 DISP1 SLC4A11 ATP6V0A2 | 1.36e-04 | 1289 | 269 | 34 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.50e-04 | 85 | 269 | 7 | GO:0019199 | |
| GeneOntologyMolecularFunction | AMP binding | 1.61e-04 | 21 | 269 | 4 | GO:0016208 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.40e-04 | 65 | 269 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.66e-04 | 129 | 269 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.11e-04 | 28 | 269 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein O-acetylglucosaminyltransferase activity | 5.38e-04 | 3 | 269 | 2 | GO:0097363 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC39A11 SLC24A3 HCN2 SLC30A2 RYR2 RYR3 ITPR1 SLC13A4 TRPV2 SLC17A6 CACNA1A HCN3 GRIA3 GRIN1 SLC17A1 SLC4A11 | 6.06e-04 | 465 | 269 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PRPS2 ERBB3 ATR SAMD8 PDK2 MATK PLK5 INSRR LRRK2 ACVR1 TRRAP PRPS1L1 PIK3CD PIK3CG PARP12 FLT4 POLR1A NTRK3 POLH ROR1 MAP3K6 ART1 DGKK ROS1 PRPS1 | 9.40e-04 | 938 | 269 | 25 | GO:0016772 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.03e-03 | 151 | 269 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.07e-03 | 4 | 269 | 2 | GO:0005219 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR13C6P OR6F1 OR2W3 OR2A4 OR10H5 OR4C45 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 3.94e-06 | 432 | 267 | 19 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR13C6P RYR2 OR6F1 OR2W3 OR2A4 OR10H5 OR4C45 CASP5 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 5.18e-06 | 524 | 267 | 21 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2A7 OR9G1 OR7C1 CDHR2 PIEZO1 OR8S1 OR13G1 ADGRV1 OR13J1 OR13C6P RYR2 OR6F1 OR2W3 OR2A4 PTPRQ OR10H5 OR4C45 CASP5 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 8.43e-06 | 722 | 267 | 25 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR13C6P OR6F1 OR2W3 OR2A4 OR10H5 OR4C45 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 1.12e-05 | 465 | 267 | 19 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR13C6P OR6F1 OR2W3 OR2A4 OR10H5 OR4C45 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 2.02e-05 | 485 | 267 | 19 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 ADGRV1 OR13J1 OR13C6P OR6F1 OR2W3 OR2A4 PTPRQ OR10H5 OR4C45 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 2.50e-05 | 582 | 267 | 21 | GO:0050906 |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 4.17e-05 | 6 | 267 | 3 | GO:0046391 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 4.17e-05 | 6 | 267 | 3 | GO:0006015 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | AHI1 LRRK2 FAM91A1 ACTN4 PIK3CD PIK3CG INSC PKHD1 AP3M2 AP3D1 KNL1 UNC13B CUL3 DCTN2 MEI1 LLGL1 MAP1S HGS DOCK7 | 9.86e-05 | 546 | 267 | 19 | GO:0051656 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR13C6P OR6F1 OR2W3 OR2A4 OR10H5 OR4C45 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 1.01e-04 | 547 | 267 | 19 | GO:0007606 |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 2.07e-05 | 5 | 269 | 3 | GO:0002189 | |
| GeneOntologyCellularComponent | apical part of cell | ERBB3 CDHR2 SLCO2B1 ACVR1 PTCH1 FAT1 AP2A1 EDAR INSC PTPRQ PKHD1 HSD11B1 USH2A AKAP7 MGAM SLC2A2 SLC3A1 SYTL4 SLC17A1 SLC4A11 | 8.95e-05 | 592 | 269 | 20 | GO:0045177 |
| GeneOntologyCellularComponent | secretory vesicle | A2M PRAMEF5 GALNS ATR ABCA13 SYT17 SPATA31A7 LRRK2 ACTN4 PSMD11 SLC30A2 F13A1 ITPR1 PCYOX1L AP2A1 PRAMEF6 AKAP7 KNL1 SLC17A6 UNC13B MGAM SPATA31A3 AKAP3 GRIN1 SPATA31A5 MYOF CLEC4D SYTL4 HGS LAMP3 FRMPD3 ATP6V0A2 | 1.55e-04 | 1246 | 269 | 32 | GO:0099503 |
| GeneOntologyCellularComponent | axon | MYCBP2 INSRR LRRK2 PTCH1 HCN2 NDRG2 NF1 HMCN2 TRPV2 AP3M2 USH2A AP3D1 SLC17A6 UNC13B AMFR GIT1 DCTN2 NTRK3 ROR1 HCN3 GRIA3 GRIN1 ADAM22 LLGL1 DOCK7 | 2.29e-04 | 891 | 269 | 25 | GO:0030424 |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.74e-04 | 25 | 269 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.35e-04 | 47 | 269 | 5 | GO:0031462 | |
| GeneOntologyCellularComponent | outer dynein arm | 4.25e-04 | 12 | 269 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | AP-3 adaptor complex | 5.48e-04 | 13 | 269 | 3 | GO:0030123 | |
| GeneOntologyCellularComponent | distal axon | LRRK2 PTCH1 NDRG2 TRPV2 USH2A AP3D1 UNC13B AMFR GIT1 DCTN2 ROR1 HCN3 GRIA3 GRIN1 DOCK7 | 5.50e-04 | 435 | 269 | 15 | GO:0150034 |
| GeneOntologyCellularComponent | dynein complex | 6.43e-04 | 54 | 269 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | HCN channel complex | 9.73e-04 | 4 | 269 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | USH2 complex | 9.73e-04 | 4 | 269 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.17e-03 | 161 | 269 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | basal part of cell | ERBB3 ABCA1 SLCO2B1 ABCA8 SLC16A12 AP2A1 SLC22A10 PTPRQ RHBG SLC2A2 LLGL1 DOCK7 SLC4A11 | 1.30e-03 | 378 | 269 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | terminal bouton | 1.51e-03 | 96 | 269 | 6 | GO:0043195 | |
| GeneOntologyCellularComponent | axon terminus | 1.65e-03 | 210 | 269 | 9 | GO:0043679 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.70e-03 | 253 | 269 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB3 CDHR2 SLCO2B1 FAT1 AP2A1 PTPRQ PKHD1 USH2A AKAP7 MGAM SLC2A2 SLC3A1 SYTL4 SLC17A1 SLC4A11 | 1.70e-03 | 487 | 269 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB3 ABCA1 SLCO2B1 ABCA8 SLC16A12 AP2A1 SLC22A10 PTPRQ RHBG SLC2A2 LLGL1 SLC4A11 | 2.23e-03 | 354 | 269 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | motile cilium | CATSPERE PRAMEF5 FSIP2 KIF9 DNAH8 DNAH9 PRAMEF6 CUL3 AKAP3 DNAH12 DNAH17 PCNT | 2.28e-03 | 355 | 269 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | NLRP1 inflammasome complex | 2.39e-03 | 6 | 269 | 2 | GO:0072558 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 2.39e-03 | 6 | 269 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 2.39e-03 | 6 | 269 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.39e-03 | 6 | 269 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 2.39e-03 | 6 | 269 | 2 | GO:1990075 | |
| Domain | PRib_PP_synth_CS | 2.70e-06 | 3 | 261 | 3 | IPR000842 | |
| Domain | PRPP_SYNTHASE | 2.70e-06 | 3 | 261 | 3 | PS00114 | |
| Domain | ARM-type_fold | VPS11 ATR LRRK2 TRRAP RYR3 ITPR1 KPNA7 NF1 AP2A1 PIK3CD PIK3CG INSC AGBL1 AP3D1 FRYL MEI1 INTS4 | 6.14e-06 | 339 | 261 | 17 | IPR016024 |
| Domain | ABC_A | 1.69e-05 | 12 | 261 | 4 | IPR026082 | |
| Domain | Pribosyltran_N | 2.64e-05 | 5 | 261 | 3 | PF13793 | |
| Domain | Pribosyl_synth | 2.64e-05 | 5 | 261 | 3 | PF14572 | |
| Domain | Rib-P_diPkinase | 2.64e-05 | 5 | 261 | 3 | IPR005946 | |
| Domain | Pribosyltran_N | 2.64e-05 | 5 | 261 | 3 | IPR029099 | |
| Domain | Ryanodine_recept-rel | 5.23e-05 | 6 | 261 | 3 | IPR015925 | |
| Domain | - | 5.23e-05 | 6 | 261 | 3 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 5.23e-05 | 6 | 261 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.23e-05 | 6 | 261 | 3 | PF08709 | |
| Domain | RIH_assoc | 5.23e-05 | 6 | 261 | 3 | PF08454 | |
| Domain | RIH_dom | 5.23e-05 | 6 | 261 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.23e-05 | 6 | 261 | 3 | IPR014821 | |
| Domain | RYDR_ITPR | 5.23e-05 | 6 | 261 | 3 | PF01365 | |
| Domain | PI3Kc | 5.94e-05 | 16 | 261 | 4 | SM00146 | |
| Domain | - | 5.94e-05 | 16 | 261 | 4 | 1.10.1070.11 | |
| Domain | L_dom-like | ERBB3 PRAMEF5 LRRC45 INSRR LRRK2 LRRC74A PHLPP1 SLITRK6 PRAMEF6 LRFN1 NTRK3 NLRP1 OMG LRR1 LRRC31 | 6.26e-05 | 328 | 261 | 15 | IPR032675 |
| Domain | PI3/4_kinase_cat_dom | 9.77e-05 | 18 | 261 | 4 | IPR000403 | |
| Domain | PI3_PI4_kinase | 9.77e-05 | 18 | 261 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 9.77e-05 | 18 | 261 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 9.77e-05 | 18 | 261 | 4 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 9.77e-05 | 18 | 261 | 4 | PS50290 | |
| Domain | LRR_6 | 1.15e-04 | 55 | 261 | 6 | PF13516 | |
| Domain | Olfact_rcpt | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR6F1 OR2W3 OR2A4 OR10H5 OR4L1 OR9G9 OR51D1 OR52A5 OR6K3 OR4F15 | 1.40e-04 | 393 | 261 | 16 | IPR000725 |
| Domain | Glycosyltransferase_AER61 | 1.95e-04 | 2 | 261 | 2 | IPR007657 | |
| Domain | DUF563 | 1.95e-04 | 2 | 261 | 2 | PF04577 | |
| Domain | Tyr_kinase_cat_dom | 2.33e-04 | 88 | 261 | 7 | IPR020635 | |
| Domain | TyrKc | 2.33e-04 | 88 | 261 | 7 | SM00219 | |
| Domain | MIR | 3.01e-04 | 10 | 261 | 3 | PF02815 | |
| Domain | MIR_motif | 3.01e-04 | 10 | 261 | 3 | IPR016093 | |
| Domain | MIR | 3.01e-04 | 10 | 261 | 3 | PS50919 | |
| Domain | MIR | 3.01e-04 | 10 | 261 | 3 | SM00472 | |
| Domain | Pribosyltran | 4.10e-04 | 11 | 261 | 3 | PF00156 | |
| Domain | Tyr_kinase_rcpt_2_CS | 4.10e-04 | 11 | 261 | 3 | IPR002011 | |
| Domain | PROTEIN_KINASE_TYR | 4.23e-04 | 97 | 261 | 7 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.23e-04 | 97 | 261 | 7 | IPR008266 | |
| Domain | ARM-like | ATR LRRK2 TRRAP KPNA7 NF1 AP2A1 INSC AGBL1 AP3D1 FRYL MEI1 INTS4 | 4.37e-04 | 270 | 261 | 12 | IPR011989 |
| Domain | RECEPTOR_TYR_KIN_II | 5.41e-04 | 12 | 261 | 3 | PS00239 | |
| Domain | PRibTrfase_dom | 5.41e-04 | 12 | 261 | 3 | IPR000836 | |
| Domain | DUF4599 | 5.41e-04 | 12 | 261 | 3 | PF15371 | |
| Domain | DUF4599 | 5.41e-04 | 12 | 261 | 3 | IPR027970 | |
| Domain | PRTase-like | 5.41e-04 | 12 | 261 | 3 | IPR029057 | |
| Domain | - | 5.41e-04 | 12 | 261 | 3 | 3.40.50.2020 | |
| Domain | DUF2075 | 5.78e-04 | 3 | 261 | 2 | PF09848 | |
| Domain | RyR | 5.78e-04 | 3 | 261 | 2 | PF02026 | |
| Domain | DUF2075 | 5.78e-04 | 3 | 261 | 2 | IPR018647 | |
| Domain | RR_TM4-6 | 5.78e-04 | 3 | 261 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.78e-04 | 3 | 261 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 5.78e-04 | 3 | 261 | 2 | IPR003032 | |
| Domain | Talin-1 | 5.78e-04 | 3 | 261 | 2 | IPR015710 | |
| Domain | Ryanrecept_TM4-6 | 5.78e-04 | 3 | 261 | 2 | IPR009460 | |
| Domain | - | PRAMEF5 LRRC45 LRRK2 LRRC74A PHLPP1 SLITRK6 PRAMEF6 LRFN1 NTRK3 NLRP1 OMG LRR1 LRRC31 | 6.15e-04 | 321 | 261 | 13 | 3.80.10.10 |
| Domain | SSD | 6.96e-04 | 13 | 261 | 3 | PS50156 | |
| Domain | SSD | 6.96e-04 | 13 | 261 | 3 | IPR000731 | |
| Domain | ATPase_dyneun-rel_AAA | 8.76e-04 | 14 | 261 | 3 | IPR011704 | |
| Domain | AAA_8 | 8.76e-04 | 14 | 261 | 3 | PF12780 | |
| Domain | AAA_5 | 8.76e-04 | 14 | 261 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.76e-04 | 14 | 261 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 8.76e-04 | 14 | 261 | 3 | IPR013602 | |
| Domain | DHC_N2 | 8.76e-04 | 14 | 261 | 3 | PF08393 | |
| Domain | LRR_1 | LRRC45 LRRK2 LRRC74A PHLPP1 SLITRK6 NTRK3 NLRP1 OMG LRR1 LRRC31 | 1.06e-03 | 219 | 261 | 10 | PF00560 |
| Domain | DHC_fam | 1.08e-03 | 15 | 261 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.08e-03 | 15 | 261 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 1.08e-03 | 15 | 261 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 1.08e-03 | 15 | 261 | 3 | IPR004273 | |
| Domain | Ion_trans_dom | 1.11e-03 | 114 | 261 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.11e-03 | 114 | 261 | 7 | PF00520 | |
| Domain | Asp/Asn-tRNA-synth_IIb | 1.15e-03 | 4 | 261 | 2 | IPR002312 | |
| Domain | PI3K_adapt-bd_dom | 1.15e-03 | 4 | 261 | 2 | IPR003113 | |
| Domain | Ion_trans_N | 1.15e-03 | 4 | 261 | 2 | IPR013621 | |
| Domain | Ion_trans_N | 1.15e-03 | 4 | 261 | 2 | PF08412 | |
| Domain | PI3K_ABD | 1.15e-03 | 4 | 261 | 2 | PS51544 | |
| Domain | - | 1.17e-03 | 222 | 261 | 10 | 1.25.10.10 | |
| Domain | Leu-rich_rpt | LRRC45 LRRK2 LRRC74A PHLPP1 SLITRK6 LRFN1 NTRK3 NLRP1 OMG LRR1 LRRC31 | 1.56e-03 | 271 | 261 | 11 | IPR001611 |
| Domain | Kinase-like_dom | ERBB3 ATR MATK PLK5 INSRR LRRK2 ACVR1 TRRAP PIK3CD PIK3CG FLT4 NTRK3 ROR1 MAP3K6 KNDC1 MACF1 ROS1 | 1.68e-03 | 542 | 261 | 17 | IPR011009 |
| Domain | tRNA-synt_2 | 1.89e-03 | 5 | 261 | 2 | PF00152 | |
| Domain | aa-tRNA-synt_II-like | 1.89e-03 | 5 | 261 | 2 | IPR018150 | |
| Domain | aa-tRNA-synt_II | 1.89e-03 | 5 | 261 | 2 | IPR004364 | |
| Domain | Pkinase_Tyr | 2.26e-03 | 129 | 261 | 7 | PF07714 | |
| Pubmed | AHI1 PRAMEF5 DZIP1L UGGT1 FAM91A1 ACTN4 PTCH1 F13A1 ITPR1 PIK3CD FMN1 CAMTA1 HERC1 COG5 PRAMEF6 PARP12 IGIP RALGPS2 SALL4 G2E3 FRYL PAICS FEM1B TGM4 VCAN PIGW MACF1 KLHDC10 ATP6V0A2 PCNT | 3.30e-09 | 1084 | 275 | 30 | 11544199 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR6F1 OR2W3 OR2A4 OR4C45 OR4L1 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 1.64e-08 | 340 | 275 | 16 | 11875048 |
| Pubmed | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR6F1 OR2W3 OR2A4 OR4C45 OR4L1 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 1.64e-08 | 340 | 275 | 16 | 11802173 | |
| Pubmed | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR6F1 OR2W3 OR2A4 OR4C45 OR4L1 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 1.85e-08 | 343 | 275 | 16 | 32295537 | |
| Pubmed | OR2A7 OR9G1 OR7C1 OR8S1 OR13G1 OR13J1 OR6F1 OR2W3 OR2A4 OR4C45 OR4L1 OR51D1 OR52A5 OR6K3 OR13C7 OR4F15 | 2.09e-08 | 346 | 275 | 16 | 14611657 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ERBB3 MYCBP2 ABCA13 FAT1 NF1 HMCN2 SPDEF DNAH9 TNS3 SLC17A6 UNC13B CUL3 RBM15 YTHDC2 MAP1S MACF1 | 3.76e-08 | 361 | 275 | 16 | 26167880 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 PIEZO1 PTCH1 TRRAP FAT1 AP2A1 PIK3CD GPC2 HERC1 AP3D1 AGAP3 UNC13B HSPG2 LRFN1 TWNK FRYL TLNRD1 MYOF INTS5 GET4 POMGNT2 MAP1S IL17RE TLN1 PIGW DISP2 PCNT | 2.57e-07 | 1105 | 275 | 27 | 35748872 |
| Pubmed | MYCBP2 UGGT1 ACTN4 URB2 TRRAP NUP205 NF1 ANKRD52 PTCD3 RBM15 POLR1A YTHDC2 FRYL PAICS TLN1 DOCK7 MACF1 ZBTB11 ZMYM3 PCNT | 3.21e-07 | 653 | 275 | 20 | 22586326 | |
| Pubmed | 4.89e-07 | 3 | 275 | 3 | 1314091 | ||
| Pubmed | A2M ERBB3 ATR ERCC6L FAM91A1 ITPR1 AP3D1 DDX11L8 PARP12 CUL3 GPAM YTHDC2 MAP3K6 LIG3 LLGL1 WDCP DOCK7 ZBTB11 CMTR2 | 1.27e-06 | 650 | 275 | 19 | 38777146 | |
| Pubmed | A2M MYCBP2 BCAT1 PSMD11 VSIR RYR2 AP2A1 HERC1 KNL1 HSPG2 FLT4 TWNK SKI CREBBP MACF1 ZNF76 ZBTB11 INVS | 1.37e-06 | 591 | 275 | 18 | 15231748 | |
| Pubmed | ACACB ACADS MYCBP2 PDK2 FAM91A1 DARS1 ACTN4 PSMD11 RYR2 ITPR1 NF1 GPR158 AKAP7 PTCD3 AGAP3 CACNA1A GIT1 GRIA3 GRIN1 ADAM22 POMGNT2 MAP1S KIAA1217 DOCK7 KNDC1 MACF1 | 1.53e-06 | 1139 | 275 | 26 | 36417873 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ERBB3 ABCA1 ACACB SYT17 INSRR OR2W3 NF1 HSD11B1 HERC1 DNAH8 TNS3 FLT4 ROR1 SLC3A1 KIAA1217 | 1.54e-06 | 420 | 275 | 15 | 28065597 |
| Pubmed | 1.80e-06 | 12 | 275 | 4 | 11700294 | ||
| Pubmed | 1.89e-06 | 47 | 275 | 6 | 8812413 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.94e-06 | 4 | 275 | 3 | 23413940 | |
| Pubmed | 1.94e-06 | 4 | 275 | 3 | 9607712 | ||
| Pubmed | MYCBP2 ADGRV1 GPR158 PHLPP1 CAMTA1 ANGPT1 MYOF TLN1 PPP1R16B MACF1 PCNT | 2.03e-06 | 225 | 275 | 11 | 12168954 | |
| Pubmed | ACTN4 ADGRV1 HCN2 ITIH1 NF1 AP3D1 PTCD3 AGAP3 GIT1 GRIA3 PAICS ADAM22 LLGL1 VCAN MACF1 | 2.06e-06 | 430 | 275 | 15 | 32581705 | |
| Pubmed | ABCA13 DZIP1L UGGT1 INSRR BCAT1 ACTN4 RYR3 UBE4A GIT1 SLC3A1 SYTL4 PCNT | 3.18e-06 | 284 | 275 | 12 | 29459677 | |
| Pubmed | 4.45e-06 | 83 | 275 | 7 | 11114734 | ||
| Pubmed | PRPS2 ACACB SLCO2B1 DZIP1L UGGT1 ATP10B ACTN4 SLC30A2 PTGFR RYR2 PRPS1L1 NUP205 AP2A1 PKHD1 SPDEF DNAH8 AP3D1 SLC17A6 PCDHGA7 TWNK GRIA3 SKI NARS2 DGKK MACF1 ZBTB11 SLC4A11 PCNT PRPS1 | 4.52e-06 | 1442 | 275 | 29 | 35575683 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PRPS2 VPS11 ERBB3 ATR ACADS SAMD8 PSMD11 ACVR1 VSIR NUP205 FAT1 NF1 AP2A1 HERC1 LRFN1 ROR1 NARS2 MYOF INTS5 GET4 NR5A2 INTS4 MACF1 ATP6V0A2 | 4.59e-06 | 1061 | 275 | 24 | 33845483 |
| Pubmed | USP25 regulates Wnt signaling by controlling the stability of tankyrases. | 6.46e-06 | 16 | 275 | 4 | 28619731 | |
| Pubmed | 9.61e-06 | 6 | 275 | 3 | 20850414 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 9.61e-06 | 6 | 275 | 3 | 25966694 | |
| Pubmed | 9.61e-06 | 6 | 275 | 3 | 20519450 | ||
| Pubmed | 9.61e-06 | 6 | 275 | 3 | 23463619 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 9.61e-06 | 6 | 275 | 3 | 25930072 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 9.61e-06 | 6 | 275 | 3 | 16844763 | |
| Pubmed | ACACB NF1 AP2A1 NYNRIN ANKRD52 AGAP3 RBM15 RALGPS2 FRYL KLC4 MAP1S HGS DOCK7 THAP12 | 1.48e-05 | 446 | 275 | 14 | 24255178 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.63e-05 | 101 | 275 | 7 | 23382219 | |
| Pubmed | 1.67e-05 | 7 | 275 | 3 | 11860456 | ||
| Pubmed | 1.67e-05 | 7 | 275 | 3 | 31178125 | ||
| Pubmed | 2.06e-05 | 21 | 275 | 4 | 26116392 | ||
| Pubmed | MYCBP2 ACSS2 HCN2 NF1 AP2A1 CACNA1A AMFR GIT1 HCN3 GRIN1 ADAM22 MACF1 | 2.37e-05 | 347 | 275 | 12 | 17114649 | |
| Pubmed | Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain. | 2.50e-05 | 22 | 275 | 4 | 26950368 | |
| Pubmed | 2.76e-05 | 150 | 275 | 8 | 32423001 | ||
| Pubmed | MCL1 ACTN4 PSMD11 AP2A1 HERC1 CUL3 AMFR HSPG2 GTF2H4 LLGL1 HGS MACF1 KLHDC10 PCNT | 3.40e-05 | 481 | 275 | 14 | 28190767 | |
| Pubmed | 3.97e-05 | 9 | 275 | 3 | 23901102 | ||
| Pubmed | 4.28e-05 | 49 | 275 | 5 | 21362503 | ||
| Pubmed | 4.77e-05 | 162 | 275 | 8 | 15174051 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB TRRAP RYR3 HERC1 AP3D1 RBM15 POLR1A COL6A6 YTHDC2 MEI1 PAICS DNAH12 MAP1S P4HA1 | 4.83e-05 | 497 | 275 | 14 | 36774506 |
| Pubmed | 5.63e-05 | 10 | 275 | 3 | 12372301 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 18033814 | ||
| Pubmed | Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory. | 6.23e-05 | 2 | 275 | 2 | 28562591 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 19297623 | ||
| Pubmed | Sequence analyses of the olfactory receptor gene cluster mOR37 on mouse chromosome 4. | 6.23e-05 | 2 | 275 | 2 | 10873383 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 26431158 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 16116162 | ||
| Pubmed | A mouse model for the learning and memory deficits associated with neurofibromatosis type I. | 6.23e-05 | 2 | 275 | 2 | 9054942 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 8898078 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 14550562 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 34638692 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 18552129 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 18409517 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 6.23e-05 | 2 | 275 | 2 | 21531043 | |
| Pubmed | PI3K/p110{delta} is a novel therapeutic target in multiple myeloma. | 6.23e-05 | 2 | 275 | 2 | 20505158 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 16678258 | ||
| Pubmed | Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. | 6.23e-05 | 2 | 275 | 2 | 16304053 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 17626838 | ||
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 6.23e-05 | 2 | 275 | 2 | 28653555 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 31691624 | ||
| Pubmed | Oligodendrocyte myelin glycoprotein does not influence node of ranvier structure or assembly. | 6.23e-05 | 2 | 275 | 2 | 20980605 | |
| Pubmed | PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. | 6.23e-05 | 2 | 275 | 2 | 33493137 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 14568546 | ||
| Pubmed | Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils. | 6.23e-05 | 2 | 275 | 2 | 18412166 | |
| Pubmed | HCN3 ion channels: roles in sensory neuronal excitability and pain. | 6.23e-05 | 2 | 275 | 2 | 31290157 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 31216371 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 2537655 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 22310717 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 26310847 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 14614902 | ||
| Pubmed | Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies. | 6.23e-05 | 2 | 275 | 2 | 18597946 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 28656280 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 15878979 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 27442134 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 10619433 | ||
| Pubmed | Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. | 6.23e-05 | 2 | 275 | 2 | 15739165 | |
| Pubmed | TNFα Post-Translationally Targets ZnT2 to Accumulate Zinc in Lysosomes. | 6.23e-05 | 2 | 275 | 2 | 25808614 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 12823463 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 31391209 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 23568740 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 18250464 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 32572717 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 15671307 | ||
| Pubmed | PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? | 6.23e-05 | 2 | 275 | 2 | 17290298 | |
| Pubmed | PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane. | 6.23e-05 | 2 | 275 | 2 | 16533525 | |
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 22357859 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 27154356 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 37833372 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 17723215 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 17644738 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 14985349 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 21520210 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 20053631 | ||
| Pubmed | 6.23e-05 | 2 | 275 | 2 | 29563550 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERCC6L MYCBP2 MATK FSIP2 NF1 TNS3 AGAP3 RBM15 GIT1 NTRK3 RALGPS2 FRYL KLC4 MAP3K6 NARS2 KIAA1217 DOCK7 MACF1 PLEKHM3 | 6.42e-05 | 861 | 275 | 19 | 36931259 |
| Pubmed | 7.70e-05 | 11 | 275 | 3 | 25624497 | ||
| Pubmed | 7.70e-05 | 11 | 275 | 3 | 24349473 | ||
| GeneFamily | ATP binding cassette subfamily A | 1.14e-05 | 14 | 192 | 4 | 805 | |
| GeneFamily | Dyneins, axonemal | 2.63e-05 | 17 | 192 | 4 | 536 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 6.24e-05 | 40 | 192 | 5 | 321 | |
| GeneFamily | Olfactory receptors, family 13 | 9.32e-05 | 23 | 192 | 4 | 162 | |
| GeneFamily | Solute carriers | SLCO2B1 SLC39A11 SLC24A3 SLC30A2 SLC16A12 SLC13A4 SLC22A10 SLC17A6 RHBG SLC2A2 SLC3A1 SLC17A1 SLC4A11 | 3.19e-04 | 395 | 192 | 13 | 752 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.34e-04 | 3 | 192 | 2 | 287 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 6.64e-04 | 4 | 192 | 2 | 1244 | |
| GeneFamily | O-linked N-acetylglucosaminyltransferases|Tetratricopeptide repeat domain containing | 6.64e-04 | 4 | 192 | 2 | 446 | |
| GeneFamily | Glypicans | 1.64e-03 | 6 | 192 | 2 | 572 | |
| GeneFamily | PRAME family | 2.02e-03 | 24 | 192 | 3 | 686 | |
| GeneFamily | Schlafen family | 2.27e-03 | 7 | 192 | 2 | 1110 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 3.01e-03 | 8 | 192 | 2 | 831 | |
| GeneFamily | Transglutaminases | 3.85e-03 | 9 | 192 | 2 | 773 | |
| GeneFamily | Cyclic nucleotide gated channels | 4.77e-03 | 10 | 192 | 2 | 250 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP | 2.61e-06 | 143 | 272 | 10 | M8819 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | SLC24A3 LIX1L ACVR1 PTCH1 NDRG2 GPC3 NYNRIN SLITRK6 ANGPT1 POLH GRIA3 GPAM MYOF SLFN13 VCAN | 1.22e-05 | 336 | 251 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | AHI1 UBE4A HMCN2 FMN1 SLITRK6 PARP12 KNL1 CUL3 SALL4 CREBBP MYOF ART1 SLC17A1 FAM222B DGKK KNDC1 MACF1 MUC6 | 2.48e-05 | 492 | 251 | 18 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA13 ADGRV1 RYR2 RYR3 FAT1 PTPRQ PKHD1 USH2A DNAH9 MGAM STAB2 SALL4 DGKK ROS1 | 5.44e-13 | 184 | 271 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA13 ADGRV1 RYR2 RYR3 FAT1 PTPRQ PKHD1 USH2A DNAH9 MGAM STAB2 SALL4 DGKK ROS1 | 5.44e-13 | 184 | 271 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA13 ADGRV1 RYR2 RYR3 FAT1 PTPRQ PKHD1 USH2A DNAH9 MGAM STAB2 SALL4 DGKK ROS1 | 5.44e-13 | 184 | 271 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 PTCH1 ABCA8 RYR2 GPC3 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 2.41e-11 | 199 | 271 | 14 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 PTCH1 ABCA8 RYR2 GPC3 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 2.57e-11 | 200 | 271 | 14 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CYP2F1 PLK5 PTPRQ PKHD1 SPDEF USH2A DNAH8 STAB2 TGM4 ANXA10 BPIFB4 PPP1R16B MUC6 | 2.15e-10 | 193 | 271 | 13 | 315840bc48899f3a36d57b19197509de19716e3d |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 FMN1 PTPRQ PKHD1 PARM1 UNC13B ROR1 SALL4 IL17RE KIAA1217 ROS1 | 2.24e-09 | 190 | 271 | 12 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M ABCA10 ABCA8 SLC16A12 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 2.38e-09 | 191 | 271 | 12 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M ABCA10 ABCA8 SLC16A12 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 2.52e-09 | 192 | 271 | 12 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ABCA1 ABCA8 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 MACF1 PDZRN3 | 3.38e-09 | 197 | 271 | 12 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PTCH1 ABCA8 GPC3 SLITRK6 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 3.79e-09 | 199 | 271 | 12 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PTCH1 ABCA8 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 4.01e-09 | 200 | 271 | 12 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | PTCH1 NDRG2 ABCA8 GPC3 SLITRK6 ANGPT1 COL6A6 ADAMTS8 SYTL4 VCAN MACF1 PDZRN3 | 4.01e-09 | 200 | 271 | 12 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | NDRG2 ABCA8 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 4.01e-09 | 200 | 271 | 12 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | PTCH1 NDRG2 ABCA8 GPC3 SLITRK6 ANGPT1 COL6A6 ADAMTS8 SYTL4 VCAN MACF1 PDZRN3 | 4.01e-09 | 200 | 271 | 12 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | NDRG2 ABCA8 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 4.01e-09 | 200 | 271 | 12 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | ABCA1 PTCH1 ABCA8 GPC3 SLITRK6 ANGPT1 COL6A6 ADAMTS8 SYTL4 VCAN MACF1 PDZRN3 | 4.01e-09 | 200 | 271 | 12 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | A2M ABCA8 SLC16A12 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 2.20e-08 | 187 | 271 | 11 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | A2M SLC24A3 RYR2 RYR3 ITPR1 HMCN2 PARM1 NTRK3 MYOF MACF1 PDZRN3 | 2.33e-08 | 188 | 271 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 PTCH1 ABCA10 ABCA8 RBMS3 DNAH8 COL15A1 ANGPT1 KIAA1217 VCAN | 2.46e-08 | 189 | 271 | 11 | 71397e993a77d70b2eeede240bdfc7660b558987 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 PTCH1 ABCA10 ABCA8 RBMS3 DNAH8 COL15A1 ANGPT1 KIAA1217 VCAN | 2.46e-08 | 189 | 271 | 11 | 4eea4759520c312bd17a681034d8074e47093d2b |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 PTGFR FMN1 PKHD1 AGBL1 PARM1 UNC13B KIAA1217 LAMP3 ROS1 | 2.74e-08 | 191 | 271 | 11 | 34cc997e4e5c727495f321e6807a84aa124da486 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 PTPRQ PKHD1 AGBL1 PARM1 UNC13B ROR1 KIAA1217 LAMP3 ROS1 | 2.74e-08 | 191 | 271 | 11 | ca5669bd6f4a17471acae3eb229f845cc2e08efa |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | LRRK2 ADGRV1 PTGFR FMN1 PKHD1 AGBL1 PARM1 UNC13B KIAA1217 LAMP3 ROS1 | 2.89e-08 | 192 | 271 | 11 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | A2M EOGT ABCA10 ABCA8 SLC16A12 RYR2 GPC3 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 3.39e-08 | 195 | 271 | 11 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | A2M SLC16A12 ITPR1 GPC3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MEI1 OMG MACF1 | 3.76e-08 | 197 | 271 | 11 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 3.76e-08 | 197 | 271 | 11 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | A2M PTCH1 NDRG2 ABCA8 GPC3 RBMS3 HSD11B1 ANGPT1 ADAMTS8 OMG MACF1 | 3.76e-08 | 197 | 271 | 11 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | A2M SLC24A3 RYR2 GPC3 COL15A1 ANGPT1 COL6A6 ROR1 VCAN MACF1 PDZRN3 | 3.76e-08 | 197 | 271 | 11 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 VCAN PDZRN3 | 4.17e-08 | 199 | 271 | 11 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 AHI1 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 MYOF VCAN PDZRN3 | 4.17e-08 | 199 | 271 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | NDRG2 ABCA8 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 MACF1 PDZRN3 | 4.39e-08 | 200 | 271 | 11 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | NDRG2 ABCA8 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 MACF1 PDZRN3 | 4.39e-08 | 200 | 271 | 11 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | A2M NDRG2 ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 4.39e-08 | 200 | 271 | 11 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | A2M NDRG2 ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 4.39e-08 | 200 | 271 | 11 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M ABCA10 ABCA8 F13A1 RYR2 RBMS3 COL15A1 NTRK3 VCAN CORIN PDZRN3 | 4.39e-08 | 200 | 271 | 11 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | A2M NDRG2 ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 4.39e-08 | 200 | 271 | 11 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CDHR2 ABCA13 CCDC178 ADGRV1 PTPRQ PKHD1 USH2A DNAH9 NTRK3 ROS1 | 6.16e-08 | 162 | 271 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | A2M ABCA8 RYR2 GPC3 PTPRQ HSD11B1 COL15A1 COL6A6 PCDHGA7 PDZRN3 | 1.41e-07 | 177 | 271 | 10 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | A2M ABCA8 RYR2 GPC3 PTPRQ HSD11B1 COL15A1 COL6A6 PCDHGA7 PDZRN3 | 1.41e-07 | 177 | 271 | 10 | db222faaecbe5600da39277243c4e7e764eb63c9 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PLK5 BCAT1 ADGRV1 RBMS3 TNS3 PARM1 IL17RE CORIN FRMPD3 SLC4A11 | 2.03e-07 | 184 | 271 | 10 | e123ad8ee46a032825a0bd4b3586ddcb3eda03d4 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | TMEM170B ABCA1 MYCBP2 ABCA8 RBMS3 PIK3CG HSD11B1 ANGPT1 ROR1 ADAM22 | 2.03e-07 | 184 | 271 | 10 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA10 ABCA8 RYR2 GPC3 HSD11B1 COL15A1 ANGPT1 COL6A6 ADAMTS8 | 2.24e-07 | 186 | 271 | 10 | 5473283fb95cee556b1f6934cf72169b676b5bcc |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-07 | 187 | 271 | 10 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PTCH1 ABCA8 SLC16A12 RYR2 GPC3 ANGPT1 COL6A6 ADAMTS8 MYOF PDZRN3 | 2.60e-07 | 189 | 271 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | PTCH1 GPC3 RBMS3 HSD11B1 SLITRK6 TNS3 ANGPT1 GRIA3 VCAN MACF1 | 2.73e-07 | 190 | 271 | 10 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.73e-07 | 190 | 271 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 ABCA10 ABCA8 RBMS3 COL15A1 ANGPT1 ROR1 KIAA1217 VCAN | 2.87e-07 | 191 | 271 | 10 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 ABCA10 ABCA8 RBMS3 COL15A1 ANGPT1 ROR1 KIAA1217 VCAN | 2.87e-07 | 191 | 271 | 10 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | A2M ABCA10 ABCA8 GPC3 HSD11B1 COL15A1 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 2.87e-07 | 191 | 271 | 10 | f12959eebb4167e1aa03de05d7711a702c58b3c9 |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | A2M ABCA10 ABCA8 GPC3 HSD11B1 COL15A1 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 2.87e-07 | 191 | 271 | 10 | 387296b5377ef6839f0812e5b3529a10b5f7d530 |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-07 | 192 | 271 | 10 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | A2M SLC24A3 RYR2 GPC3 TNS3 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 3.01e-07 | 192 | 271 | 10 | 62904f94dfce430456f05066522cbf9bd29f4d7e |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | A2M EOGT NDRG2 SLC16A12 RYR2 GPC3 RBMS3 ANGPT1 ADAMTS8 PDZRN3 | 3.31e-07 | 194 | 271 | 10 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | A2M ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 3.31e-07 | 194 | 271 | 10 | 3c2266772c5b56e8e02a461e5193e29588028ee9 |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | A2M ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 3.47e-07 | 195 | 271 | 10 | ffcf76cd72e43d8cf1058a49c76e0956065038bc |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | A2M ABCA10 ABCA8 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 3.47e-07 | 195 | 271 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 MYCBP2 UGGT1 INSRR HERC1 CACNA1A COL6A6 FRYL SLC2A2 MACF1 | 3.47e-07 | 195 | 271 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA10 ABCA8 RYR2 GPC3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 3.47e-07 | 195 | 271 | 10 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA10 ABCA8 RYR2 GPC3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 3.47e-07 | 195 | 271 | 10 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 MYCBP2 UGGT1 INSRR HERC1 CACNA1A COL6A6 FRYL SLC2A2 MACF1 | 3.47e-07 | 195 | 271 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-07 | 196 | 271 | 10 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | A2M ABCA10 ABCA8 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 3.64e-07 | 196 | 271 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA8 RYR2 GPC3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 3.64e-07 | 196 | 271 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA10 ABCA8 GPC3 HSD11B1 COL15A1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 3.64e-07 | 196 | 271 | 10 | 42e9828222a9663525d571633e8a454c30bfa7f8 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | A2M ABCA8 RYR2 GPC3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 3.64e-07 | 196 | 271 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-07 | 196 | 271 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 PTCH1 ABCA8 GPC3 RBMS3 PARM1 ANGPT1 KIAA1217 VCAN | 3.81e-07 | 197 | 271 | 10 | b349f8e96d61a4c296af64711e11fc44459a9413 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 PTCH1 ABCA8 GPC3 RBMS3 PARM1 COL15A1 ANGPT1 VCAN | 3.81e-07 | 197 | 271 | 10 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.81e-07 | 197 | 271 | 10 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | A2M SLC24A3 PTCH1 ABCA8 GPC3 RBMS3 PARM1 ANGPT1 KIAA1217 VCAN | 3.81e-07 | 197 | 271 | 10 | c2e390653d5dee7e731c1840cfdab41987dede9b |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | NDRG2 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN MACF1 | 4.00e-07 | 198 | 271 | 10 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | A2M ABCA10 ABCA8 RYR2 GPC3 RBMS3 ANGPT1 COL6A6 ADAMTS8 PDZRN3 | 4.00e-07 | 198 | 271 | 10 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-07 | 198 | 271 | 10 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-07 | 198 | 271 | 10 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.00e-07 | 198 | 271 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 ACSS2 PTGFR FMN1 AGBL1 PARM1 UNC13B ROR1 KIAA1217 LAMP3 | 4.19e-07 | 199 | 271 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-07 | 199 | 271 | 10 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 ACSS2 PTGFR FMN1 AGBL1 PARM1 UNC13B ROR1 KIAA1217 LAMP3 | 4.19e-07 | 199 | 271 | 10 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN PDZRN3 | 4.19e-07 | 199 | 271 | 10 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 GPC3 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 VCAN PDZRN3 | 4.19e-07 | 199 | 271 | 10 | 211c3a08f2d484ab7a3368006767289088f0d957 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN MACF1 PDZRN3 | 4.19e-07 | 199 | 271 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | A2M ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 4.19e-07 | 199 | 271 | 10 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN PDZRN3 | 4.19e-07 | 199 | 271 | 10 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | NDRG2 GPC3 ANGPT1 COL6A6 RALGPS2 ADAMTS8 MYOF SYTL4 VCAN PDZRN3 | 4.19e-07 | 199 | 271 | 10 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | A2M ABCA8 RYR2 GPC3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 PDZRN3 | 4.19e-07 | 199 | 271 | 10 | 66a79732caf2f04c09b4d9832377aa01ca477677 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | A2M ABCA8 RYR2 GPC3 RBMS3 HSD11B1 ANGPT1 COL6A6 ADAMTS8 MACF1 | 4.19e-07 | 199 | 271 | 10 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 GPC3 ANGPT1 COL6A6 ADAMTS8 MYOF SYTL4 VCAN PDZRN3 | 4.19e-07 | 199 | 271 | 10 | 1a0add79f4e34078b3475eb11c85a4234bda197c |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.38e-07 | 200 | 271 | 10 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.38e-07 | 200 | 271 | 10 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-07 | 200 | 271 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M ABCA10 ABCA8 RYR2 GPC3 ANGPT1 COL6A6 ADAMTS8 VCAN PDZRN3 | 4.38e-07 | 200 | 271 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M PTCH1 ABCA10 ABCA8 F13A1 SLITRK6 COL15A1 NTRK3 VCAN PDZRN3 | 4.38e-07 | 200 | 271 | 10 | fb53be20392a8309a7393774c774a1b1aec6e676 |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.38e-07 | 200 | 271 | 10 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.38e-07 | 200 | 271 | 10 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.38e-07 | 200 | 271 | 10 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-07 | 200 | 271 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M ABCA10 ABCA8 GPC3 RBMS3 COL15A1 ANGPT1 COL6A6 VCAN PDZRN3 | 4.38e-07 | 200 | 271 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.38e-07 | 200 | 271 | 10 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | A2M ABCA10 ABCA8 RYR2 HSD11B1 COL15A1 NTRK3 ADAMTS8 CORIN PDZRN3 | 4.38e-07 | 200 | 271 | 10 | 16a3685c41194a0a4a772e4eee372160263480e0 |
| Drug | abrine | DARS1 ADGRV1 OR6F1 PKHD1 SPDEF DNAH8 STAB2 ANGPT1 DHX58 MAP3K6 CIDEC DGKK NR5A2 DOCK7 INVS | 1.54e-06 | 285 | 267 | 15 | ctd:C496492 |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A | AHI1 CDHR2 NDRG2 FOXRED2 NF1 EDAR CACNA1A ARL4C MYOF DNAH17 NR5A2 PPP1R16B | 3.73e-06 | 196 | 267 | 12 | 2531_DN |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A | SLC24A3 GPC3 AKAP7 FLT4 STAB2 RHBG MAP3K6 OMG ARL4C LLGL1 WDCP DNAH17 | 4.36e-06 | 199 | 267 | 12 | 5523_UP |
| Drug | Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; HL60; HG-U133A | ATR ACADS CDHR2 UGGT1 BCAT1 GIT1 NTRK3 OMG ARL4C MYOF INTS5 VCAN | 4.59e-06 | 200 | 267 | 12 | 1788_UP |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | PDK2 BCAT1 NDRG2 NF1 GPC3 HSPG2 NTRK3 GRIN1 ADAM22 CIDEC ZNF76 | 1.69e-05 | 191 | 267 | 11 | 5667_UP |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | ABCA1 MCL1 PTCH1 NDRG2 NF1 CACNA1A NLRP1 ARL4C ART1 VCAN MACF1 | 1.95e-05 | 194 | 267 | 11 | 2469_DN |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | A2M ABCA1 ACADS ATP10B NF1 NTRK3 CREBBP ART1 DNAH17 ZNF76 MUC6 | 2.25e-05 | 197 | 267 | 11 | 5563_UP |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | AHI1 PDK2 ZNF230 RYR2 AKAP7 CACNA1A GIT1 RHBG YTHDC2 ADAM22 DNAH17 | 2.25e-05 | 197 | 267 | 11 | 3930_DN |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | ZBTB48 SLC24A3 ITPR1 EDAR PIK3CD RALGPS2 GRIN1 MTERF4 ADAM22 LIG3 MACF1 | 2.25e-05 | 197 | 267 | 11 | 7021_UP |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; HL60; HG-U133A | ABCA1 ERCC6L NDRG2 AP3D1 UNC13B NTRK3 MTERF4 LIG3 FAM222B TLN1 INVS | 2.25e-05 | 197 | 267 | 11 | 1721_UP |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | ACADS SYT17 BCAT1 NDRG2 F13A1 PIK3CD RALGPS2 SKI LLGL1 ART1 LAMP3 | 2.25e-05 | 197 | 267 | 11 | 2836_UP |
| Drug | estradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A | ATR PDK2 ACTN4 NF1 PARM1 CACNA1A AMFR NTRK3 ADAM22 FEM1B LLGL1 | 2.47e-05 | 199 | 267 | 11 | 373_UP |
| Drug | methyl iodoacetate | 3.11e-05 | 6 | 267 | 3 | CID006429536 | |
| Drug | APP-MP | 3.11e-05 | 6 | 267 | 3 | CID003081102 | |
| Drug | pyrimidine-5-nucleotide | 3.11e-05 | 6 | 267 | 3 | CID000440040 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 6.31e-06 | 31 | 253 | 5 | C1335167 | |
| Disease | Adenoid Cystic Carcinoma | 2.55e-05 | 100 | 253 | 7 | C0010606 | |
| Disease | Autosomal recessive polycystic kidney disease | 7.32e-05 | 2 | 253 | 2 | cv:C0085548 | |
| Disease | uric acid measurement | ABCA1 INSRR ACVR1 ADGRV1 FMN1 SLC22A10 ANKRD52 FLT4 POLR1A SKI SLC2A2 MYOF SLC17A1 UNC5CL NR5A2 ZMYM3 | 8.36e-05 | 610 | 253 | 16 | EFO_0004761 |
| Disease | Large cell carcinoma of lung | 1.57e-04 | 32 | 253 | 4 | C0345958 | |
| Disease | Fibrosarcoma | 2.18e-04 | 3 | 253 | 2 | C0016057 | |
| Disease | cleft lip, alcohol exposure measurement | 2.18e-04 | 3 | 253 | 2 | EFO_0003959, EFO_0009113 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.18e-04 | 3 | 253 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.18e-04 | 3 | 253 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Seckel syndrome 1 | 2.18e-04 | 3 | 253 | 2 | C4551474 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.79e-04 | 67 | 253 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.96e-04 | 195 | 253 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | lipoprotein measurement | 2.97e-04 | 105 | 253 | 6 | EFO_0004732 | |
| Disease | serum gamma-glutamyl transferase measurement | ACADS MCL1 BCAT1 RYR2 ITPR1 UBE4A NF1 EDAR RBMS3 PKHD1 TWNK NLRP1 SKI OMG SLC2A2 MAP1S SYTL4 TLN1 MUC6 | 3.73e-04 | 914 | 253 | 19 | EFO_0004532 |
| Disease | Ciliopathies | 3.81e-04 | 110 | 253 | 6 | C4277690 | |
| Disease | FEV/FEC ratio | ERBB3 DZIP1L KIAA0586 MCL1 SLC24A3 ACVR1 PTCH1 VSIR ITPR1 RBMS3 HERC1 AP3D1 PTCD3 AGAP3 HSPG2 MGAM COL15A1 ZNF781 MEI1 DNAH12 SYTL4 PDZRN3 ATP6V0A2 | 4.03e-04 | 1228 | 253 | 23 | EFO_0004713 |
| Disease | free cholesterol measurement | 4.40e-04 | 113 | 253 | 6 | EFO_0008591 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 5.45e-04 | 19 | 253 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of salivary gland | 5.97e-04 | 45 | 253 | 4 | C0220636 | |
| Disease | Gastric Adenocarcinoma | 5.97e-04 | 45 | 253 | 4 | C0278701 | |
| Disease | Salivary Gland Neoplasms | 7.05e-04 | 47 | 253 | 4 | C0036095 | |
| Disease | Fuchs Endothelial Dystrophy | 7.20e-04 | 5 | 253 | 2 | C0016781 | |
| Disease | JOUBERT SYNDROME 17 | 7.20e-04 | 5 | 253 | 2 | C3553264 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 7.20e-04 | 5 | 253 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Sarcoma | 7.39e-04 | 21 | 253 | 3 | C1261473 | |
| Disease | Bipolar Disorder | ERBB3 ACADS ABCA13 ITIH1 ITPR1 DNAH8 SLC17A6 CACNA1A ROR1 GRIA3 GRIN1 PCNT | 9.22e-04 | 477 | 253 | 12 | C0005586 |
| Disease | Glioma | 9.29e-04 | 87 | 253 | 5 | C0017638 | |
| Disease | Malignant neoplasm of breast | ERBB3 CATSPERE SLCO2B1 DTX3L ACVR1 NF1 GPC2 HSD11B1 DNAH9 SLC17A6 AMFR POLH ROR1 MAP3K6 SLC2A2 LLGL1 WDCP MACF1 KLHDC10 PRPS1 | 1.03e-03 | 1074 | 253 | 20 | C0006142 |
| Disease | diverticular disease | 1.04e-03 | 236 | 253 | 8 | EFO_0009959 | |
| Disease | Exfoliation Syndrome | 1.07e-03 | 6 | 253 | 2 | C0206368 | |
| Disease | protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 measurement | 1.07e-03 | 6 | 253 | 2 | EFO_0801956 | |
| Disease | glucagon measurement, glucose tolerance test | 1.07e-03 | 6 | 253 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Fuchs' endothelial dystrophy (is_implicated_in) | 1.07e-03 | 6 | 253 | 2 | DOID:11555 (is_implicated_in) | |
| Disease | PR interval | MYCBP2 RYR2 PRPS1L1 FAT1 CAMTA1 HSPG2 SKI ADAM22 GET4 MACF1 THAP12 PDZRN3 | 1.26e-03 | 495 | 253 | 12 | EFO_0004462 |
| Disease | sexual dimorphism measurement | ABCA1 MCL1 ACSS2 PTCH1 ABCA8 PRPS1L1 NF1 RBMS3 NYNRIN SPDEF HERC1 AP3D1 AKAP7 MGAM GPAM FRYL OMG SLC17A1 MACF1 ATP6V0A2 | 1.46e-03 | 1106 | 253 | 20 | EFO_0021796 |
| Disease | hereditary angioedema (is_implicated_in) | 1.49e-03 | 7 | 253 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | cortical thickness | A2M ERBB3 MYCBP2 ACTN4 ADGRV1 PTCH1 PKHD1 CAMTA1 AGBL1 AGAP3 HSPG2 ANGPT1 ROR1 RALGPS2 DNAAF9 ADAMTS8 ARL4C VCAN DOCK7 MACF1 | 1.58e-03 | 1113 | 253 | 20 | EFO_0004840 |
| Disease | Epileptic encephalopathy | 2.13e-03 | 30 | 253 | 3 | C0543888 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.14e-03 | 105 | 253 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 2.24e-03 | 64 | 253 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | 6-bromotryptophan measurement | 2.53e-03 | 9 | 253 | 2 | EFO_0800099 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.53e-03 | 9 | 253 | 2 | C0085548 | |
| Disease | facial hair thickness measurement | 2.57e-03 | 32 | 253 | 3 | EFO_0007823 | |
| Disease | Glioblastoma Multiforme | 2.73e-03 | 111 | 253 | 5 | C1621958 | |
| Disease | Malignant Glioma | 3.11e-03 | 70 | 253 | 4 | C0555198 | |
| Disease | mixed gliomas | 3.11e-03 | 70 | 253 | 4 | C0259783 | |
| Disease | Colorectal Carcinoma | ABCA1 GALNS ABCA13 ABCA10 ABCA8 FAT1 NF1 PKHD1 DNAH8 UNC13B AKAP3 ITPRID1 LIG3 PRPS1 | 3.16e-03 | 702 | 253 | 14 | C0009402 |
| Disease | facial emotion recognition measurement | 3.33e-03 | 35 | 253 | 3 | EFO_0008329 | |
| Disease | free cholesterol in small HDL measurement | 3.33e-03 | 35 | 253 | 3 | EFO_0022270 | |
| Disease | sleep disorder (implicated_via_orthology) | 3.83e-03 | 11 | 253 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 3.83e-03 | 11 | 253 | 2 | EFO_0800279 | |
| Disease | migraine disorder | 3.88e-03 | 357 | 253 | 9 | MONDO_0005277 | |
| Disease | acylcarnitine measurement | 4.85e-03 | 127 | 253 | 5 | EFO_0005059 | |
| Disease | esterified cholesterol measurement | 5.01e-03 | 128 | 253 | 5 | EFO_0008589 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.17e-03 | 243 | 253 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | hyperglycemia (is_marker_for) | 5.37e-03 | 13 | 253 | 2 | DOID:4195 (is_marker_for) | |
| Disease | central corneal thickness | 5.42e-03 | 309 | 253 | 8 | EFO_0005213 | |
| Disease | platelet component distribution width | AHI1 LRRK2 KIF9 NYNRIN CAMTA1 HERC1 FLT4 ANGPT1 SKI SYTL4 TLN1 DOCK7 PPP1R16B MACF1 | 5.93e-03 | 755 | 253 | 14 | EFO_0007984 |
| Disease | lip morphology measurement | 5.95e-03 | 189 | 253 | 6 | EFO_0007845 | |
| Disease | response to anticonvulsant | 6.21e-03 | 85 | 253 | 4 | GO_0036277 | |
| Disease | lipoprotein measurement, phospholipid measurement | 6.21e-03 | 85 | 253 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 6.23e-03 | 14 | 253 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Sarcoma, Spindle Cell | 6.23e-03 | 14 | 253 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 6.23e-03 | 14 | 253 | 2 | C0205944 | |
| Disease | macrophage inflammatory protein 1b measurement | 6.46e-03 | 136 | 253 | 5 | EFO_0008219 | |
| Disease | testosterone measurement | ERCC6L SLC24A3 ABCA8 UBE4A NF1 RBMS3 NYNRIN SLC22A10 USH2A TNS3 KNL1 POLR1A RALGPS2 GPAM SYTL4 DGKK ANXA10 KNDC1 MACF1 PLEKHM3 | 7.14e-03 | 1275 | 253 | 20 | EFO_0004908 |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 7.14e-03 | 15 | 253 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | hepatoblastoma (is_marker_for) | 7.14e-03 | 15 | 253 | 2 | DOID:687 (is_marker_for) | |
| Disease | Alobar Holoprosencephaly | 7.14e-03 | 15 | 253 | 2 | C0431363 | |
| Disease | ascending aortic diameter | 7.28e-03 | 140 | 253 | 5 | EFO_0021787 | |
| Disease | lipid measurement, lipoprotein measurement | 7.58e-03 | 90 | 253 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | Gastrointestinal Stromal Sarcoma | 7.65e-03 | 47 | 253 | 3 | C3179349 | |
| Disease | phosphoglycerides measurement | 8.11e-03 | 48 | 253 | 3 | EFO_0022291 | |
| Disease | Schizoaffective disorder-bipolar type | 8.12e-03 | 16 | 253 | 2 | EFO_0009965 | |
| Disease | Lobar Holoprosencephaly | 8.12e-03 | 16 | 253 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 8.12e-03 | 16 | 253 | 2 | C0751617 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 8.12e-03 | 16 | 253 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.40e-03 | 145 | 253 | 5 | DOID:1289 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLGALFTQMLEVGTT | 1226 | Q14146 | |
| DDNTVHFNSTLMALI | 1886 | O00555 | |
| HLSSAMANVVFTQLL | 791 | Q96P47 | |
| QSFQAVTDHMLAIGS | 751 | P21860 | |
| DQLRITHNTDIFIGM | 411 | Q5NDL2 | |
| DIVSQFGMETVILHT | 161 | Q6NSW5 | |
| IESTSSLHLMQFQAN | 666 | Q9Y6Y1 | |
| ETSGHFRDTLMNLVQ | 146 | Q9UJ72 | |
| SNISAFQSLHIVMLG | 6 | P56559 | |
| NLVFGTVFTDHMLTV | 46 | P54687 | |
| GNLSMLSNDSIIHEV | 486 | Q5SY80 | |
| SILSHEEQMFVNRVG | 3206 | P13611 | |
| TAGMAQITHLDNYLS | 281 | Q8WWZ4 | |
| ATAISHQAIQILGGM | 356 | P16219 | |
| MLTAQEILHQFGFTQ | 1021 | Q8N157 | |
| AISGMLQQSDALHSA | 36 | P59827 | |
| VSDGSFHITLLVMQL | 121 | Q9P0M2 | |
| GADLQNHILTLMSVA | 236 | Q9UP79 | |
| LLHSLGTLAQELFSM | 261 | O95477 | |
| GLAVMHSQSTNQLDV | 356 | Q04771 | |
| AAFAMVIITGSDLHN | 5351 | Q8WXG9 | |
| SIEMNGTLEDQLSHL | 676 | O43707 | |
| MAVTLAQSLAHNIGI | 366 | Q9P0K1 | |
| LNDQHMGVVTAAVSL | 196 | O95782 | |
| GLAVTMASSIDQGHL | 2386 | Q92793 | |
| LTGLQNFISSMATVH | 216 | Q8IYT2 | |
| LGHTLLNLSGFNMEE | 4341 | Q86UQ4 | |
| MLNGEVSLTSGHAII | 4766 | Q86UQ4 | |
| LQMVHTLASNGANSI | 61 | Q9Y2X7 | |
| QNHTATMLEIGTSLL | 121 | Q15389 | |
| MLNVSGHLLSTAEVE | 571 | Q9NR19 | |
| HELLISTLMTNGADT | 351 | Q8NB46 | |
| EQAMQFGQLLTHLDT | 341 | Q13561 | |
| FGQLLTHLDTTQQMI | 346 | Q13561 | |
| GGLDMLILNHITNTS | 111 | P28845 | |
| TVSITLQHAALSMFV | 596 | Q96F81 | |
| MEQDQIRSHTSFGAL | 311 | A7MBM2 | |
| QLQDHATSVGSFLMQ | 331 | Q8IUZ5 | |
| METAQHLENQLTLLG | 871 | O94823 | |
| EHGLVQFSINTTNVM | 401 | P01023 | |
| MAEQEASGLQVLLHT | 1 | Q96MI9 | |
| SFHEGTDVIMLTTNQ | 101 | O14617 | |
| MGNTSNLFLQNLSHI | 401 | Q9HCJ3 | |
| SNMHLLQGDLQVASS | 801 | Q96T37 | |
| TGTQTDITFEHIMAL | 356 | Q9UPQ7 | |
| MFHLNSLTGEISTLE | 291 | Q9Y5G6 | |
| HMIGLQSSSTLGTLN | 236 | Q9H8K7 | |
| MQRSNHTVTEFILLG | 1 | Q8NH87 | |
| FAMDQGTATLHVQAS | 1846 | P98160 | |
| LTQQMNHLSLGTTGT | 336 | Q6XE24 | |
| DTLLMTTHNLLFGGT | 286 | P24903 | |
| LLSSDHILGITMGNQ | 101 | Q68DA7 | |
| LGSMEQVSSHFLEQT | 306 | Q96HW7 | |
| VHQGLSLSQEAVSVM | 71 | P0C1H6 | |
| SELMLGGTNTLVLHN | 401 | Q9NPH2 | |
| LTSSMAQHLQAAGQV | 1631 | Q92621 | |
| ATVTQMHFLTGQGRL | 76 | Q15334 | |
| FHSVLENLTNVMSGF | 996 | O00763 | |
| MIHSLFLINSSGDIF | 1 | P53677 | |
| STLQQLLMQTGTHSY | 151 | Q8IYY4 | |
| GLSEAQVMLALASHL | 81 | Q9NSK0 | |
| NMAGLSTNTTVLVHL | 1741 | Q14517 | |
| HLQMATSFGLELVVQ | 496 | Q6W4X9 | |
| HSLENSEGILLTTMA | 121 | Q8NGY3 | |
| HVSVLMGSVNASANI | 1101 | Q5KSL6 | |
| DMFDQLLQAGTTVSL | 171 | Q96EY7 | |
| MQGLNHTSVSEFILV | 1 | Q8NGA6 | |
| LGNGVLILMTVSNSH | 41 | Q8NH95 | |
| LGNGVLILMTVSNSH | 41 | P0DN81 | |
| MNHSVVTEFIILGLT | 1 | Q8NGZ3 | |
| TGATMDQLIQLVHSG | 396 | A9QM74 | |
| MTGSNSHITILTLNV | 1 | O00370 | |
| SMIEEHAFQVLSQGS | 41 | Q96LI6 | |
| TAQLLQFSLHVAEGM | 326 | P42679 | |
| HQALGITVLGSNSMV | 1031 | Q66K74 | |
| LSNHASILIMLTDGD | 391 | P19827 | |
| LGLSQMLHIASQIAS | 651 | Q16288 | |
| LTGHQEAQFMTTLKA | 836 | Q6ZRS4 | |
| GASNLVIDLIMNASS | 1811 | Q14643 | |
| MFGLLLHLEAATNSN | 11 | Q5SSG8 | |
| SFIQGTTTMNLHSVA | 366 | Q96L50 | |
| FLEMLSVAQHSLTQL | 111 | Q8N158 | |
| MENVLLGLFSTIHDS | 316 | P51654 | |
| LDTLTHATNFLNVML | 126 | Q5T848 | |
| HVEFATGELLTMTQV | 4481 | Q8NDA2 | |
| AVGQMVNLNTLTLDH | 181 | Q9P244 | |
| SAHGVLLLNSNAMDV | 1181 | O43451 | |
| QGHLATALIIAMSTI | 181 | Q9UNE0 | |
| NVLTMLNDALTHSAV | 586 | Q658Y4 | |
| NLLSQTGVLHMASFG | 1851 | Q15751 | |
| SMDTQAQQLILHFSS | 366 | Q8NFR9 | |
| QEESSNLMQHILGFF | 841 | Q5BJE1 | |
| NLMQHILGFFQTLTD | 846 | Q5BJE1 | |
| IISLVEAGAHTDMTN | 556 | Q9UK73 | |
| LSDTIGFLMVNAISN | 6281 | Q5CZC0 | |
| DSGTIQMLLNHSFTL | 1231 | O95382 | |
| IGGLFMRNTVQEHSA | 36 | P42263 | |
| HQILQTMPGIATFSS | 211 | Q9H2K0 | |
| LVTMANIGINGNHSL | 266 | P43088 | |
| MTQHSVAESLLQVGV | 186 | Q8NBM8 | |
| SMSLVLHGNNLLVFG | 156 | Q6PID8 | |
| MNNVTEFILLGLTHN | 1 | A6NMZ5 | |
| LAQMFLIHALSAVES | 111 | Q8NGF3 | |
| MDGTNGSTQTHFILL | 1 | Q7Z3T1 | |
| IHSFQAIESGILLAM | 106 | Q9H2C5 | |
| IGFLHSISQIVLTMN | 151 | Q8NH43 | |
| ALQGGHVDTSLFQMA | 1171 | Q9C000 | |
| LSFQLLSHTQMNTGL | 11 | Q8WU58 | |
| DLVSMAHGIQNLINA | 251 | Q96JB1 | |
| GFTSASTQEMTVHLL | 2066 | O94915 | |
| VALMLHVAQQFSGIN | 306 | P11168 | |
| FVGGTLLSITQQMHL | 126 | Q6UY01 | |
| STTGHSTNFVIAMLL | 3056 | Q6ZR08 | |
| SEHALLLLFSNGMVQ | 261 | Q496M5 | |
| EHLGQMLAINVGLTS | 236 | Q0VAA2 | |
| ILVLAAGQLGNMHSS | 321 | Q8IVB5 | |
| MLTVHNASVNLSVIG | 121 | Q5S007 | |
| LNHLFEGSNTSLDIM | 466 | Q5S007 | |
| MGQLLEQASLHFFVT | 596 | P00488 | |
| GNDFMDLTFNHTLQI | 341 | Q8NG31 | |
| LFASLAVILHDGSQM | 11 | Q9UQV4 | |
| EQAMGHSQDRLTTFQ | 221 | Q96CN5 | |
| FEGETNRIIASHTMN | 196 | Q9HAQ2 | |
| MTFHGQQSIRTVIDT | 486 | Q96RR1 | |
| LVSMHGAQLVTTLFL | 341 | Q8NAT1 | |
| THINENMVLAGAISG | 191 | Q96R45 | |
| GNTAIMAVSVLDIHL | 41 | Q8NGT2 | |
| GNLVIVFTVTMDAHL | 41 | Q8NGB8 | |
| IMQEVEHALSSGSIA | 246 | Q6UWI2 | |
| MQRSNHTVTEFILLG | 1 | P0C7N8 | |
| HFQSISVLGNLEARM | 261 | Q6ZWE6 | |
| LVQEFDMTSATHVLG | 966 | P49916 | |
| NILGVTNFIHMLSRS | 231 | Q8IWF2 | |
| MFIGHATALIQSLDS | 341 | Q9P1Z3 | |
| SEQETLSMIAHLGVF | 3166 | O95613 | |
| HQLSFSEAGLRIMIT | 321 | Q9HC58 | |
| TASQSENLLFQLMTH | 1961 | Q9UPN3 | |
| RMLINQHTLIFDGST | 166 | Q15119 | |
| DHSMAQTLQASLEGL | 1231 | Q5TIA1 | |
| TSGTFMQNFTLHEVT | 1031 | Q9UMZ3 | |
| THINENMVLAGAISG | 191 | O95047 | |
| AGSLTAVLHSLNEVM | 511 | O43422 | |
| DTQTHTMFLARVLVG | 611 | Q9H0J9 | |
| FFTSIGQMTDLIHTE | 21 | P13674 | |
| QMAELLVSHGASLSA | 276 | Q96T49 | |
| METGNQTHAQEFLLL | 1 | O76099 | |
| AIIITMHQEDFSGSL | 616 | Q9UP83 | |
| TAGQVSHQLGSIMDL | 331 | P34059 | |
| SHQLGSIMDLFTTSL | 336 | P34059 | |
| LMQHLENSSLFEGSL | 416 | Q7L622 | |
| LSTQTVFSMLDHLTQ | 1576 | Q13535 | |
| SVSQNFSVAMVTIHL | 456 | Q9BYE9 | |
| ILQSGLDNFVINHML | 21 | P51878 | |
| TAIHLMNIVSSAGSL | 401 | Q96N67 | |
| GLFSTIMRDLANITH | 2181 | Q9UFH2 | |
| VHFVLNQESMTLTGL | 481 | Q8TDB6 | |
| THMLAAITGSFQVLS | 1686 | Q5JV73 | |
| NTTMDEFRQHLQATG | 481 | Q13618 | |
| MHIEGFLAALTTANQ | 566 | A8MPP1 | |
| SSQGHLQIFDMFVVE | 166 | Q5TEA3 | |
| QLLIGAGNSSQSTHM | 401 | Q96C10 | |
| TLSINVNSSSFLMVH | 691 | Q9Y5Q5 | |
| VFGMHTEISITLFDN | 156 | Q5I0G3 | |
| MASGHSLLLENAQQV | 1 | Q96NU7 | |
| VEGHLQILLMFTATG | 51 | P14616 | |
| HLMENGALVLTTNFD | 151 | Q9BPY3 | |
| VSETLSMLGQHFGQL | 216 | Q1MX18 | |
| FATAMQILSGLEHLA | 1581 | Q76NI1 | |
| NITIFAVMFSHLSAG | 16 | A6NJ69 | |
| SFTMDQDTTLAHLLQ | 1396 | Q9NYC9 | |
| LSNSLINITHGFMNF | 801 | P39059 | |
| DIVSQFGMETVILHT | 161 | Q8TCE6 | |
| ADLTTLMHNENLNGV | 201 | Q9UKG4 | |
| MLQGHSSVFQALLGT | 1 | Q8N1S5 | |
| GSHMSQQVSAAVALL | 261 | Q9UJQ4 | |
| TALNSEHMNTLLGNI | 3266 | Q92736 | |
| LAGTQHMEALLQSLV | 541 | Q68D06 | |
| AMFIGHATALIQSLD | 456 | Q9UL51 | |
| MNSVSFLEGHLDQLL | 181 | H0Y7S4 | |
| SNAIDQMAHIGQTTL | 686 | A6NMZ7 | |
| QMAHIGQTTLTGSAL | 691 | A6NMZ7 | |
| LSGMFDASLVNHVLL | 136 | Q2NKX8 | |
| GSHDLDSNQAAMVLI | 91 | Q969Z0 | |
| LSRVMIHVFSDGVTN | 246 | Q07820 | |
| LALSSKHQFQMEGLL | 731 | Q9P2P1 | |
| GNVAILMLVSTSHQL | 41 | Q8NGZ6 | |
| NLHALMAVVSGLQSA | 136 | Q86X27 | |
| QFMLEHGALSIAAIQ | 541 | Q9Y283 | |
| GATLNNLMSHAQELV | 421 | O00482 | |
| TVGQSLLHQTQMGDI | 151 | Q96C24 | |
| VLSEGMATQQTLHGL | 4781 | O75445 | |
| THSGQATAVLSLLIM | 551 | Q8NBS3 | |
| VRTNSQGHTMAIITF | 231 | Q96GJ1 | |
| INFDMSSLVVSLAHG | 1536 | O95602 | |
| LLNNGLTMLHTNDFS | 71 | Q9H5Y7 | |
| LTMLHTNDFSGLTNA | 76 | Q9H5Y7 | |
| LENASLVFTVFGHNM | 401 | Q9BSW7 | |
| GDHSMINLSVQQVLS | 6 | Q5T4T1 | |
| TMFVTSLSVPGQHLQ | 246 | Q96LT4 | |
| NVLTMLNDALTHSAV | 231 | P0C866 | |
| HGQQNSAADLSMLVL | 76 | Q7L5D6 | |
| MILGHLFSQEELSGN | 196 | Q9UN36 | |
| FTLTVTSLHLVFQMG | 3776 | Q6P3W6 | |
| FTLTVTSLHLVFQMG | 651 | Q8N660 | |
| VGVSHQQAAFLMSIL | 311 | Q6ZSM3 | |
| FLTVSGQLHLEVMSG | 216 | Q96I59 | |
| GQLHLEVMSGAFTQV | 221 | Q96I59 | |
| GTMVNLQHVGSNIFL | 366 | Q63ZE4 | |
| DMGFSNAHINELLSV | 101 | Q7Z6M4 | |
| LQATLDMQSGIIHAA | 206 | O00231 | |
| SGNSEDVVMHAIQLL | 526 | Q9HCL2 | |
| SMLHVNIKENGFLSS | 291 | Q14916 | |
| MLANLQATSEDVHGF | 966 | Q8IWB4 | |
| TGKLVSAHALQTMFQ | 351 | Q13635 | |
| NGSAMQSLFIEEIHS | 941 | Q5T5P2 | |
| LAGTQHMEALLQSLV | 541 | Q7Z7L1 | |
| VLNFGESTLLNLHNM | 596 | Q07837 | |
| NHTAVLLMDGQVFTF | 1001 | O75592 | |
| NFLHMSVQSDDVLLG | 471 | P49221 | |
| MQGEITNSSLSLHVG | 1306 | P08F94 | |
| TLVSHGSVPQLFSQM | 236 | Q9Y253 | |
| VTMLFLGLHNVRQTS | 476 | P14868 | |
| NMLNLAVHLVSQASG | 386 | Q6P9B9 | |
| LNSVEMESLTGHQAI | 1316 | Q68CZ2 | |
| MALGNHSTITEFLLL | 1 | Q8NH09 | |
| TMDLHASQIQGFFDI | 126 | P21108 | |
| HMDVAVNFSQGALLS | 141 | Q86UD1 | |
| ATLTIHLQDGMVTNT | 351 | P23515 | |
| GLQKTLEQFHLSSMS | 16 | P12755 | |
| NITTGLINLMVDTLH | 456 | Q7Z7B1 | |
| HQVNDFSSLLTMDLG | 51 | O94911 | |
| LHSVTGTLMTDTQFV | 341 | O75969 | |
| FSVEVMHTTNILGIT | 436 | Q9UKV5 | |
| ALFSMQATGHVLLGT | 191 | Q96AQ7 | |
| GAHLMTISTEAEQNF | 116 | Q8WXI8 | |
| VEGMSDSLLNFLQHL | 251 | Q92759 | |
| NIMITETGNLFHIDF | 951 | P48736 | |
| QITAAFTMIGTSSHL | 201 | Q01973 | |
| LIGQTEVDIMSHATQ | 156 | P22234 | |
| MLANLQATSEDVHGF | 966 | Q5VYP0 | |
| QKLSMNSVSFLEGHL | 271 | Q5VXH4 | |
| MDGSFVQHSVRVLQE | 1 | P10074 | |
| LGVAIVDMVNNSTIH | 91 | Q9P2U8 | |
| VLVAFGSMLNTHQSQ | 296 | Q6NUS8 | |
| VAHAVSILTAGMQEQ | 961 | O95625 | |
| LTVHENLNFMAIGFT | 146 | Q9H270 | |
| MLANLQATSEDVHGF | 966 | Q5VU36 | |
| ATSQAMHQLFGLFVT | 386 | Q9H310 | |
| TETQHLSVVGIMFVA | 181 | O94956 | |
| GFNVAVLLTNLSEHM | 3991 | Q15413 | |
| EGISQEALHTQMLTA | 1691 | Q9Y490 | |
| GLTLEEHSLEQVQSM | 111 | O95238 | |
| TMDLHASQIQGFFDI | 126 | P11908 | |
| HGNFSITMRNLTLLD | 126 | Q9H7M9 | |
| EGSFSQVSTMALHIA | 1196 | P35916 | |
| DSAVLSLFQSINGMH | 436 | O14964 | |
| QKLSMNSVSFLEGHL | 271 | Q5TYX0 | |
| TDSQGNTVLHALVMI | 241 | Q9Y5S1 | |
| NTVLHALVMISDNSA | 246 | Q9Y5S1 | |
| TNEIIVTMHTFQDGL | 361 | Q8IV45 | |
| NLLNANVDSGLMHSI | 1151 | P21359 | |
| LMLSFNNSLDVAAHL | 2086 | P21359 | |
| SDNIMIRESGQLFHI | 896 | O00329 | |
| ILTHDVQSQLNMGRF | 91 | Q9H1K6 | |
| DMLATSLQGNFLHLA | 1081 | Q8WWQ8 | |
| EVTHIFLNISGTMLN | 621 | P08922 | |
| LNTVLDELSMVFGNS | 1211 | O14795 | |
| SQVEQLISMGANVHS | 521 | Q9H6S0 | |
| QVGMLDTLHQSGSEL | 491 | Q96MP5 | |
| THLVDMAGSSVDVQL | 521 | Q96MP5 | |
| VMLENFTNLLSVGHQ | 36 | Q9UIE0 | |
| LENYSNLVSMGHSIS | 36 | Q969W8 | |
| AAVGVMHNLQTFLLD | 731 | O60346 | |
| TMDLHASQIQGFFDI | 126 | P60891 | |
| ILNHMVTASAGSLVL | 1696 | Q92508 | |
| QLARFHNIMSNETIG | 841 | Q14139 | |
| HNIMSNETIGTLAFL | 846 | Q14139 | |
| TVQQTFGLSLIEMLH | 631 | Q9H6R7 | |
| TAIMTRLHNLAQFEG | 3816 | Q9Y4A5 | |
| EFILVRNHMSVSNVG | 221 | Q8N8C0 | |
| GLQTAEEHMQLSFTN | 1221 | Q14202 | |
| LQALGSAISMVTQHG | 451 | P36508 | |
| SALFINGLHMDLDTQ | 391 | Q9NYU2 | |
| QLTAAAENILMGHSL | 1331 | Q9BVV6 | |
| FNFGEILMTQVIHSI | 726 | Q9Y487 | |
| AVAVNIIMGLTLHQS | 136 | Q9BRI3 | |
| LSAVFHSATMLQDVG | 576 | Q9NZM1 | |
| HSATMLQDVGEAIQF | 581 | Q9NZM1 | |
| LVSVGLMEALQAQSH | 11 | P52961 | |
| NVSLSILKSHENGFM | 771 | Q05586 |